CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in clinical trial retrieved 24 April 2024 from https://medicalxpress.com/news/2024-04-car-cell-therapy-her2-antigen.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Jul 15, 2020Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Private and secure generative AI tool supports operations and research in a cancer centerDana-Farber Cancer Institute has implemented an artificial intelligence (AI) application intended for general use in a medical center or hospital. The system, called GPT4DFCI, is permitted for operations, administrative, and research uses but prohibited in direct clinical care.
Source: medical_xpress - 🏆 101. / 51 Read more »
Clinical trial data show investigational cancer vaccine may elicit lasting immune response in pancreatic cancerNew data presented by Memorial Sloan Kettering Cancer Center (MSK) researchers show an experimental approach to treating pancreatic cancer with the messenger RNA (mRNA)-based therapeutic cancer vaccine candidate, autogene cevumeran, continues to show potential to stimulate an immune response that may reduce the risk of the disease returning after...
Source: medical_xpress - 🏆 101. / 51 Read more »
New lab assay could make diagnosis and treatment of lung cancer easierA new lab assay developed by researchers at Fred Hutch Cancer Center could make diagnosis and treatment of small-cell lung cancer and non-small cell lung cancer easier.
Source: NewsMedical - 🏆 19. / 71 Read more »
Shape-shifting cancer cell discovery reveals potential skin cancer drug targetsCancer cells can change shape to travel around the body and spread (metastasize), but how they know when to do this has remained elusive.
Source: medical_xpress - 🏆 101. / 51 Read more »
Risk for second primary breast cancer low in certain young breast cancer patientsYoung breast cancer (BC) survivors (40 years or younger) without a pathogenic variant (PV) have a low risk for developing second primary BC (SPBC), according to a study published online April 11 in JAMA Oncology.
Source: medical_xpress - 🏆 101. / 51 Read more »
New Lancet Commission on Breast Cancer: Transforming breast cancer care globallyThe new Lancet Commission on Breast Cancer today released findings and recommendations on improving breast cancer care globally.
Source: NewsMedical - 🏆 19. / 71 Read more »